EE296 Cost-Effectiveness of Faricimab in Patients With Neovascular Age-Related Macular Degeneration in Canada
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.543
https://www.valueinhealthjournal.com/article/S1098-3015(22)02747-4/fulltext
Title :
EE296 Cost-Effectiveness of Faricimab in Patients With Neovascular Age-Related Macular Degeneration in Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02747-4&doi=10.1016/j.jval.2022.09.543
First page :
Section Title :
Open access? :
No
Section Order :
10069